Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Exploring the Immunomodulatory Effects of Liposomal Daunorubicin on Jurkat Cells: A Study of Apoptosis and Gene Expression in Co-Cultured Mda-Mb-231 Cells Publisher



Mk Shanan Malik KAREEM ; A Arasteh AMIR ; Mm Mohammadamoli Mahsa MOHAMMAD ; M Ebrahimi MEHDI
Authors

Source: Pharmaceutical Sciences Published:2025


Abstract

Background: Breast cancer represents a significant aspect of women’s health, constituting approximately 30% of cancers affecting them globally, with a mortality rate of around 15%. In the quest for healing, immunotherapy has emerged as a beacon of hope, employing our body’s innate defenses to confront cancer. Cytotoxic T lymphocyte-associated protein 4 (CTLA-4) acts as a guardian, regulating immune responses, while COX-1’s influence on inflammation and invasion in cancer is modest yet notable. This study aims to explore the immunomodulatory effects of liposomal daunorubicin (LipDau) on Jurkat cells, evaluating the cancer cell fate through apoptosis and the expression of CTLA-4 and COX-1 genes in MDA-MB-231 cells as they co-exist with Jurkat cells. Methods: We assessed cell cytotoxicity in MDA-MB-231 cells under various treatments using the MTT assay. The apoptosis process was traced through flow cytometry, comparing controls, LipDau treatments, Jurkat cells, and activated Jurkat cells. The expression of CTLA-4 and COX-1 genes in MDA-MB-231 cells was measured through real-time PCR across similar treatments. Results: The application of LipDau, particularly in the presence of activated Jurkat cells, led to a significant decline in MDA-MB-231 cells, correlating with LipDau concentrations. Activated Jurkat cells demonstrated a lower IC50 than LipDau (21.5 and 31.1 μM, respectively). Notably, apoptosis rates rose sharply in MDA-MB-231 cells co-cultured with Jurkat cells at IC50 concentrations of LipDau, accompanied by decreased expression of CTLA-4 and COX-1 genes following treatment. Conclusion: Through the nurturing guidance of LipDau-activated Jurkat cells, a protective response emerged against tumor cells in MDA-MB-231, moderated by the CTLA-4 checkpoint and a suppression of inflammatory pathways via COX-1. These interactions facilitated the journey towards apoptosis and a halt in the relentless spread of metastatic breast cancer. © 2025 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer: From Immunological Mechanisms to Clinical Evidence, International Immunopharmacology (2021)
2. Tumor Immunology, Clinical Immunology (2022)
3. Immunopathology and Immunotherapy for Breast Cancer, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (8)
Mohammad Hossein Ghahremani (1)
Other Related Docs
4. Immunotherapeutic Efficacy of a Lactobacillus Caseilysate As an Adjuvant Combined With a Heated-4T1mammary Carcinoma Cell Lysate in a Murine Model Ofbreast Cancer, Asian Biomedicine (2016)
5. Anti-Ctla-4 Nanobody As a Promising Approach in Cancer Immunotherapy, Cell death & disease (2024)
6. Ctla-4: As an Immunosuppressive Immune Checkpoint in Breast Cancer, Current Molecular Medicine (2023)
7. Blockade of Tlr4 Using Tak-242 (Resatorvid) Enhances Anti-Cancer Effects of Chemotherapeutic Agents: A Novel Synergistic Approach for Breast and Ovarian Cancers, Immunologic Research (2019)
8. The Paradox of Th17 Cell Functions in Tumor Immunity, Cellular Immunology (2017)
9. The Immunobiology of Myeloid-Derived Suppressor Cells in Cancer, Tumor Biology (2016)
10. Toll-Like Receptor Pathway and Its Targeting in Treatment of Cancers, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
11. Anti-Cancer Impact of Hypericin in B-Cpap Cells: Extrinsic Caspase Dependent Apoptosis Induction and Metastasis Obstruction, European Journal of Pharmacology (2021)
12. Conjugated Nanoliposome With the Her2/ Neu-Derived Peptide Gp2 As an Effective Vaccine Against Breast Cancer in Mice Xenograft Model, PLoS ONE (2017)
13. Pd-1/Pd-L1 Pathway: Basic Biology and Role in Cancer Immunotherapy, Journal of Cellular Physiology (2019)
14. The Molecular Landscape of T Cell Exhaustion in the Tumor Microenvironment and Reinvigoration Strategies, International Reviews of Immunology (2024)
15. Caspase-Dependent Apoptosis Induced by Two Synthetic Halogenated Flavanones, 3′,7-Dichloroflavanone and 3′,6-Dichloroflavanone, on Human Breast and Prostate Cancer Cells, In Vitro Cellular and Developmental Biology - Animal (2018)
16. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
17. Immune Checkpoint Inhibitors: Review of the Existing Evidence and Challenges in Breast Cancer, Immunotherapy (2021)
18. Review of Recent Preclinical and Clinical Research on Ligand-Targeted Liposomes As Delivery Systems in Triple Negative Breast Cancer Therapy, Journal of Liposome Research (2024)
19. Immunogenic Cell Death (Icd)-Inducers in Non-Small-Cell Lung Carcinoma (Nsclc): Current Knowledge and Future Perspective, Clinical and Translational Oncology (2023)
20. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)